SP
Praxis Precision Medicines Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RESILIENCE Program | Developmental and Epileptic Encephalopathy (DEE) | Phase 2/3 |
| ENERGY Program | Essential Tremor & Focal Onset Seizures | Phase 2/3 |
| EMBOLD Study | SCN2A/SCN8A DEE in children | Phase 2/3 |
| EMBRAVE Study | Early-onset SCN2A DEE in children | Phase 2/3 |
| EMERALD Study | Developmental and Epileptic Encephalopathies (DEE) | Phase 2/3 |
| Essential3 Study | Essential Tremor | Phase 2/3 |
| POWER1 Study | Focal Onset Seizures in adults | Phase 2/3 |
Leadership Team at Praxis Precision Medicines
MS
Marcio Souza
President & Chief Executive Officer
TK
Tim Kelly
Chief Financial Officer
AW
Alyssa Wyant
Chief Regulatory & Quality Officer
MS
Megan Sniecinski
Chief Operating Officer
KM
Kelly McCue
Chief People Officer
KH
Karl Hansen
Chief Technical Operations Officer
AN
Alex Nemiroff
General Counsel
BS
Brian Spar
Chief of Staff
DM
Dean Mitchell
Chairman of the Board
DM
Dr. Merit Cudkowicz
Director